Patents
Literature
Patsnap Eureka AI that helps you search prior art, draft patents, and assess FTO risks, powered by patent and scientific literature data.

39results about How to "Reduce pathogenicity" patented technology

Bacterial surface modification method based on atom transfer radical polymerization reaction mediation, modified bacteria and application of modified bacteria

The invention discloses a bacteria surface modification method based on atom transfer radical polymerization reaction mediation, obtained bacteria and application. The modification method comprises the following steps: carrying out acryloylation on the surfaces of the bacteria by using N-hydroxysuccinimide acrylate, and introducing double bonds on the surfaces of the bacteria to obtain acryloylated bacteria; the method comprises the following steps: by taking acrylamide, N-(3-aminopropyl) methacrylamide hydrochloride and N, N '-methylene bisacrylamide as monomers, carrying out polymerization reaction on the surfaces of acrylated bacteria in the presence of an initiator and a catalyst; the mass ratio of the acrylamide to the N-(3-aminopropyl) methacrylamide hydrochloride to the N, N '-methylene bisacrylamide is (11.9 to 17.5) to (0.125 to 1) to (0.1 to 0.5). According to the method, bacteria can be camouflaged to reduce immunogenicity and pathogenicity of the bacteria, the safety of bacteria treatment is improved under the condition that the viability and multiplication capacity of the bacteria are not affected, the resistance of the bacteria to environmental threats is enhanced, and the bacteria are endowed with no exogenous functions.
Owner:ANHUI MEDICAL UNIV

Phytophthora plant pathogenic oomycete arginine methyltransferase protein as well as coding gene and application thereof

ActiveCN119242606Areduce outputReduced growth rateBiocideFungiBiotechnologySporeling
The invention discloses arginine methyltransferase protein from phytophthora plant pathogenic oomycetes as well as a coding gene and application thereof. The arginine methyltransferase protein provided by the invention is as shown in sequences 6-8; the coding gene is shown in sequences 1-3. Experiments prove that the protein disclosed by the invention plays an important role in growth, development and pathopoiesis processes of typical phytophthora plant pathogen oomycete phytophthora capsici, and after the protein is deleted or the expression level is reduced, the growth rate of phytophthora capsici hyphae is reduced, the sporangium yield is reduced, the number of zoospore is reduced, the pathogenicity is reduced and the like. Corresponding arginine methyltransferase inhibitors have different degrees of activity on typical plant pathogenic oomycetes such as phytophthora capsici, phytophthora sojae and phytophthora infestans. The gene provided by the invention has great application potential in the aspect of preventing and controlling the crop epidemic diseases caused by phytophthora plant pathogenic oomycetes, and a novel bactericide developed based on the protein as an action target has important practical significance in controlling the occurrence and prevalence of the crop epidemic diseases caused by phytophthora.
Owner:CHINA AGRI UNIV

Application of bacteriophage in reduction of cholera propagation

According to the application of the bacteriophage to reduction of cholera transmission, the bacteriophage phi YSZKA is preserved in the China Center for Type Culture Collection on August 1, 2018, the preservation number is CCTCC NO: M 2018513, and the bacteriophage phi YSZKA is classified and named as klebsiella pneumoniae bacteriophage phi YSZKA. The method solves the problems of secondary pollution, wide transmission of vibrio cholerae and the like of the traditional split bacteriophage. The application of the bacteriophage can reduce the toxin production efficiency of vibrio cholerae in oceans, soil and sewers, thereby providing more possibilities for prevention and control of cholera epidemic situation and alleviation of cholera symptoms.
Owner:NANJING AGRICULTURAL UNIVERSITY

Application of magnaporthe oryzae Pmk1 protein K347 site as target for inhibiting pathogenicity of magnaporthe oryzae and preventing and controlling rice blast

InactiveCN119101675Areduce pathogenicityGrowth inhibitionBiocideFungiPyricularia griseaEngineered genetic
The invention belongs to the technical field of gene engineering, and provides application of a magnaporthe oryzae Pmk1 protein K347 site as a target for inhibiting the pathogenicity of magnaporthe oryzae. Researches find that after the K347 site of the magnaporthe oryzae Pmk1 protein is mutated, the pathogenicity of magnaporthe oryzae is remarkably reduced, growth and expansion of magnaporthe oryzae hyphae can be inhibited, autophagy in the conidium germination process can be promoted, and secretion of effect protein of magnaporthe oryzae can be inhibited. Compared with the drug design aiming at the whole Pmk1 gene, the drug design aiming at the K347 site disclosed by the invention is accurate in range and has very high specificity and biological safety. The invention provides a new target site for developing a pyricularia grisea antibacterial drug, and the site has good application prospect and value in the aspect of preventing and controlling the rice blast.
Owner:PLANT PROTECTION RES INST OF GUANGDONG ACADEMY OF AGRI SCI

HSPA8 protein for resisting duck tembusu virus and application of HSPA8 protein

ActiveCN119080953AGood antiviral effectPrevent proliferation in the bodyViral antigen ingredientsAntiviralsTembusu virusProkaryotic expression
The invention discloses an HSPA8 protein capable of resisting a duck tembusu virus and application of the HSPA8 protein. According to the invention, a prokaryotic expression vector for expressing HSPA8 is constructed, protein expression conditions are optimized, and soluble endotoxin-removed HSPA8 protein, including HSPA8-His protein and GST-HSPA8 protein, is expressed and purified. An in-vitro antiviral experiment shows that the HSPA8 protein disclosed by the invention has a good antiviral effect; in-vivo antiviral experiments show that the HSPA8 protein can significantly weaken pathogenicity caused by DTMUV infection, prevent in-vivo proliferation of viruses, weaken mouse weight loss caused by virus infection and reduce mouse death caused by virus infection. Therefore, the HSPA8 protein disclosed by the invention has a remarkable characteristic of resisting DTMUV infection, can be applied to preparation of drugs for resisting the duck tembusu virus, and provides a new strategy for prevention and control of the duck tembusu virus.
Owner:SICHUAN AGRI UNIV

Application of DsHAD gene in regulation and control of growth, reproduction, pathogenicity and adversity resistance of Didymeria segeticola

ActiveCN119120539Areduce pathogenicityReduced growth rateCompound screeningFungiBiotechnologyMelaleuca alternifolia
The invention discloses an application of a DsHAD gene in regulation and control of the growth, the reproduction, the pathogenicity and the stress resistance of Ddymeria segeticola. The DsHAD gene is derived from Ddymeria segeticola, and a knockout mutant is obtained by constructing a knockout gene segment of the DsHAD gene of the D. segeticola and introducing the knockout gene segment into a D. segeticola protoplast. It is found through experiments that the DsHAD gene plays a role in the growth, reproduction and adversity resistance of D.segeticola, and the pathogenicity of D.segeticola to tea tree leaves is remarkably reduced. Therefore, the DsHAD can be used as a bactericide target and a key protein of a disease pathogenic mechanism, is used for researching and developing medicaments for diseases caused by D.segeticola infection and cultivating new varieties of disease-resistant plants, and has a wide application prospect in prevention and treatment of plant pathogenic fungal diseases.
Owner:GUIZHOU UNIV

Application of isoliensinine in preparation of medicine for treating staphylococcus aureus infectious arthritis

InactiveCN119235855AReduce the ability to invadereduce pathogenicityAntibacterial agentsOrganic active ingredientsIsoliensinineStaphylococcus aureus
The invention discloses an application of isoliensinine in preparation of a medicine for treating staphylococcus aureus infectious arthritis. According to a treatment model of SD rat staphylococcus aureus infectious arthritis, the isoliensinine is proved to be capable of improving excessive inflammatory response of joint tissues infected by staphylococcus aureus and remarkably relieving pathological injury of rat joints, and the isoliensinine has a relatively good treatment effect on staphylococcus aureus infectious arthritis. In addition, the invention reveals that the isoliensinine is combined with a staphylococcus aureus reaction regulatory factor SaeR in a targeted manner, so that the toxicity of staphylococcus aureus is reduced to play a role. Compared with the traditional antibiotic for treating staphylococcus aureus, the isoliensinine has the advantages of no survival pressure on germs and no generation of drug resistance of the germs. Therefore, the isoliensinine has a relatively good potential application prospect in research and development of safe and effective medicines for treating the staphylococcus aureus infectious arthritis.
Owner:ZHONGKE JUYAN (JILIN) STEM CELL TECH CO LTD

Compound microbial flora for preventing and controlling tomato bacterial wilt as well as preparation method and application of compound microbial flora

The invention discloses a method for carrying out various machine learning modeling by utilizing global public data to construct a synthetic flora with broad-spectrum adaptability, and the constructed and simplified synthetic flora is composed of three strains of bacteria, namely, Pseudomonas putida YDTA3, Pseudomonas putida PPF1 and Snotrophomonas sp. Syn-C. The invention also discloses a method for constructing the synthetic flora with broad-spectrum adaptability, and the constructed and simplified synthetic flora is composed of three strains of bacteria, namely Pseudomonas putida YDTA3, Pseudomonas putida PPF1 and Snotrophomonas sp. Syn-C. Compared with a single bacterium, the synthetic flora constructed by the invention has higher environmental adaptability, and the strain for constructing the synthetic flora is irreplaceable and unique. After the synthetic flora is added to the rhizosphere of the continuous cropping tomato, the pathogenicity of pathogenic bacteria is inhibited, so that the morbidity of the bacterial wilt of the continuous cropping tomato is remarkably reduced.
Owner:NANJING AGRICULTURAL UNIVERSITY

Application of DspckA gene in regulation and control of pathogenicity of D.segeticola and application of DspckA gene as bactericide target

The invention discloses an application of DspckA in regulation and control of the pathogenicity of Didymeria segeticola and application of the DspckA as a bactericide target. The DspckA gene disclosed by the invention is derived from D.segeticola, and a knockout mutant is obtained by constructing a knockout gene segment of the DspckA gene and introducing the knockout gene segment into a D.segeticola protoplast. It is found through experiments that the DspckA gene plays a role in the pathogenicity of D.segeticola and the sensitivity of the DspckA gene to ningnanmycin. Molecular docking analysis and trace thermophoresis experiments prove that the DspckA protein can be used as a bactericide target and has interaction with ningnanmycin, and amino acids at T264, T265 and E306 are key binding sites. The DspckA can be used as a bactericide target and a key protein of a disease pathogenic mechanism, and has a wide application prospect in prevention and treatment of plant pathogenic fungal diseases.
Owner:GUIZHOU UNIV

Gene CcUOX of Colletotrichum camelliae and its application

The invention provides a CcUOX gene of Colletotrichum camelliae and an application thereof. The CcUOX gene is related to pathogenicity and purine metabolism, belongs to the technical field of microbial genetic engineering, comes from Colletotrichum camelliae, and its cDNA sequence consisting of 906 nucleotides is shown in SEQ ID NO:1; a protein encoded by the provided CcUOX gene has an amino acid sequence consisting of 301 amino acids as shown in SEQ ID NO:2; the CcUOX gene can be applied in the field of tea tree anthracnose resistance genetic engineering, and can be applied in the fields of food science and engineering; an engineering strain expressing the CcUOX gene can be used for the degradation, utilization and environmental restoration of caffeine waste, and can be applied to uric acid degradation; and CcUOX can be used as a gene target in the design and screening of fungicidal bacteria for Colletotrichum camelliae.
Owner:JILIN UNIVERSITY

Medical application of sanguinarine in preparation of salmonella flagellum inhibitor

InactiveCN119632986Areduce pathogenicityprevent slidingAntibacterial agentsOrganic active ingredientsBiotechnologySanguinarine
The invention provides medical application of sanguinarine in preparation of a salmonella flagellum inhibitor, and belongs to the technical field of biological medicine. According to the invention, the flagellum of salmonella is used as a potential target for researching and developing the anti-salmonella toxicity drug, and a natural product capable of inhibiting the flagellum of salmonella is screened through a salmonella sliding motion inhibition test and a real-time fluorescent quantitative PCR test; in combination with tests such as a minimum inhibitory concentration determination test, a growth curve, inhibition of salmonella from adhesion to Caco-2 cells and the like, it is verified that sanguinarine can effectively inhibit the salmonella flagellum-mediated swimming ability on the basis of not influencing normal growth of bacteria, so that the pathogenic potential of salmonella is remarkably reduced, the effect of bacteriostasis instead of sterilization is achieved, and the application prospect is broad. A new research thought and a candidate natural compound are provided for prevention and treatment of salmonella infection, and potential practical application value is achieved.
Owner:JILIN UNIVERSITY

Construction and application of gene VII type Newcastle disease attenuated marker vaccine strain rMG7-HN-G256E

The invention discloses a gene VII type Newcastle disease attenuated marker vaccine strain rMG7-HN-G256E, the preservation number of the gene VII type Newcastle disease attenuated marker vaccine strain is CGMCC (China General Microbiological Culture Collection Center) No.46292, and the whole-genome nucleotide sequence of the vaccine strain is as shown in SEQ ID No: 1; wherein the 256th amino acid glycine (G) of the HN protein is replaced by glutamic acid (E). A Newcastle disease virus reverse genetic manipulation platform is utilized, different sites are mutated on the basis of a Newcastle disease virus MG7 strain, a gene VII type Newcastle disease virus marker vaccine attenuated strain rMG7-HN-G256E which is low in pathogenicity, good in growth characteristic, high in virus titer, stable in passage and excellent in immunogenicity is rescued, and the marker vaccine strain is good in immunogenicity, high in immunogenicity, high in immunogenicity, high in specificity, high in specificity and high in specificity. The vaccine can induce a high-level protective antibody, completely protects immunized chickens, can be used for preventing and controlling the current epidemic gene VII type Newcastle disease virus, and lays a foundation for identifying vaccine immunity and wild virus infection.
Owner:LANZHOU VETERINARY RESEARCH INSTITUTE CHINESE ACADEMY OF AGRICULTURAL SCIENCES(LANZHOU BRANCH CENTER OF CHINA ANIMAL HEALTH & EPIDEMIOLOGY CENTER)

Application of rice blast fungus gene trs85 or protein encoded thereby in inhibiting pathogenicity of rice blast fungus

ActiveCN117143901Breduce pathogenicitygood control effect
This invention relates to the field of genetic engineering, specifically to the application of the rice blast fungus gene trs85 or its encoded protein in inhibiting the pathogenicity of rice blast fungus. Addressing the current lack of effective targets for rice blast fungus, this invention uses a high-throughput knockout system to study the effect of gene trs85 on the pathogenicity of rice blast fungus. It was found that knocking out gene trs85 inhibited autophagy in the mutant, reducing pathogenicity, thus demonstrating that protein trs85 is a potential target for rice blast control. Based on protein modeling of trs85, this invention performs virtual screening to obtain a drug that can inhibit rice blast fungus. This drug has a significant control effect on rice blast fungus, especially at a concentration of 50 μM where the control effect is optimal.
Owner:ZHEJIANG UNIV

Small molecule polypeptide gp04 from phage and its application in targeting quorum sensing lasr protein

PendingCN122541522Areduce pathogenicityAchieve multi-level control
This application relates to a phage-derived small molecule polypeptide Gp04 and its application in targeting the quorum sensing LasR protein, belonging to the field of biomedical technology. The amino acid sequence of the phage-derived small molecule polypeptide Gp04 is shown in SEQ ID NO.1. The small molecule polypeptide Gp04 provided in this application can inhibit the QS-related phenotype of *Pseudomonas aeruginosa* through overexpression or exogenous addition. Bacterial two-hybrid and electrophoretic mobility assays confirmed the binding and inhibitory effect of the small molecule polypeptide Gp04 on LasR. This small molecule polypeptide can be used to prepare formulations that inhibit the virulence and biofilm formation of *Pseudomonas aeruginosa*, providing new ideas and methods for developing novel antibacterial strategies targeting QS and for phage-based co-prevention of pathogenic bacterial infections.
Owner:HAINAN UNIV

Application of fisetin in preparation of medicine for preventing and treating vibriosis of mariculture animals

The invention belongs to the technical field of prevention and control of bacterial diseases of aquaculture animals, and relates to a new indication of fisetin, in particular to application of fisetin in preparation of a medicine for preventing and controlling vibriosis of mariculture animals. It is found for the first time that the natural compound fisetin inhibits formation of a vibrio harveyi virulence factor biological membrane, the fisetin is applied to prevention and treatment of vibrio harveyi diseases of mariculture animals, especially the vibrio harveyi diseases of groupers, and the relative survival rate of the groupers infected with the vibrio harveyi diseases can be increased by 50% at most. The fisetin serves as a natural compound for inhibiting formation of a main vibrio virulence factor biological membrane, has the advantages of being green, safe, efficient, low in drug resistance probability and the like, and has good application potential in the aspects of preventing and treating vibriosis of mariculture animals and bacterial diseases of aquatic animals.
Owner:HAINAN UNIV +1

Medical application of tectorigenin in preparation of salmonella fimbriae inhibitor

The invention relates to medical application of tectorigenin in preparation of a salmonella fimbriae inhibitor. Tests such as a salmonella sliding motion inhibition test, a minimum inhibitory concentration determination test, a growth curve test, a test for inhibiting salmonella from being adhered to Caco-2 cells, a biofilm determination test and the like verify that the tectorigenin can inhibit bacterial pilus-mediated adhesion to host cells on the premise of not inhibiting bacterial growth; therefore, the pathogenicity of the salmonella is reduced. The tectorigenin mainly exists in tectoridae plants blackberry lily and iris tectorum, and has the characteristics of low toxicity, no residue or low residue and low drug resistance. Therefore, when the tectorigenin is used for preventing and treating salmonella infection, the drug selectivity can be improved, and the tectorigenin has a wide application prospect and is of great significance to the development of new drugs.
Owner:JILIN UNIVERSITY

Phytophthora gls1 protein, encoding gene and application thereof

ActiveCN121555474Breduce pathogenicityReduce stress damage marker protein contentMicrobiological testing/measurementMicroorganism based processesBiotechnologySporeling
This invention discloses a glucosidase protein (GLS1) from *Phytophthora*, a plant pathogenic oomycete, its encoding gene, and its applications. The PsGLS1 protein provided by this invention is effective against *Phytophthora soybean* (…). Phytophthora sojae The protein in this invention is shown in SEQ ID No. 1; its encoding gene is shown in SEQ ID No. 2. Experiments have demonstrated that the protein provided by this invention plays an important role in the growth and development of *Phytophthora soybeani*. PsGLS1 Gene knockout significantly reduced the mycelial growth rate, sporangium number, zoospore yield, and resting spore germination rate of *Phytophthora soybeani*, and also significantly affected the pathogenicity of the fungus. The glucosidase inhibitor sericite also inhibited the mycelial growth of *Phytophthora soybeani*. In summary, this invention… PsGLS1 Genes have high application value in controlling the occurrence and spread of diseases caused by Phytophthora, and provide molecular targets for the development of new fungicides in the future.
Owner:CHINA AGRI UNIV

Application of ceramide in the control of rice blast fungus

PendingCN122074492AIncrease coercion effectIncrease contentBiocideFungicidesBiotechnologySphingolipid metabolism
The application of ceramide in the control of rice blast fungus falls within the field of biological control. This invention relates to the application of ceramide in the control of rice blast fungus: a combination of ceramide and lipopeptides is used for the control of rice blast fungus. Exogenous addition of ceramide significantly enhances the stress effect of lipopeptides on rice blast fungus. It also enhances the abnormal accumulation of glycogen and lipid droplets in conidia, promotes the bursting of ROS, and increases intracellular ceramide and calcium... 2+ The invention increases the content of malondialdehyde (MDA) in mycelium, enhances membrane lipid peroxidation, and decreases ergosterol content. Furthermore, it inhibits the expression of ergosterol synthesis genes, UPR target genes, and sphingolipid metabolism-related genes. This invention develops a highly efficient natural agent against rice blast by combining exogenous Cer with lipopeptides. This agent effectively reduces the pathogenicity of rice blast fungus and significantly inhibits its infection of rice, laying the foundation for the development of novel biological control agents.
Owner:HEILONGJIANG UNIV

Gene PlIRP1 and application thereof in preventing and treating litchi downy blight

The invention discloses a gene PlIRP1 and application of the gene PlIRP1 in prevention and control of litchi downy blight, and belongs to the technical field of green prevention and control of crop diseases. According to the present invention, based on a polyethylene glycol mediated protoplast transformation technology and a CRISPR / Cas9 knockout strategy, a PlIRP1 knockout vector is constructed, PEG-mediated protoplast transformation is performed, and a homologous recombination method is adopted to knock out the gene PlIRP1 from peronophythora litchii so as to obtain the knockout mutant; compared with a wild type, the pathogenicity and oospore yield of the mutant are obviously reduced. The invention proves that PlIRP1 is necessary for sexual coordination and infection pathopoiesis of peronophythora litchii. The research is helpful for deeply illuminating the pathogenic molecular mechanism of peronophythora litchii, and a target gene is provided for developing effective bactericides.
Owner:SOUTH CHINA AGRICULTURAL UNIVERSITY

Chicken coccidiosis protozoa reduction device using microwave field

The present invention relates to a device for reducing protozoa of chicken coccidiosis using a microwave field, and more particularly, to a device for reducing protozoa of chicken coccidiosis using a microwave field in order to recycle a mattress for second to fifth rearing after first rearing in a process of rearing broiler chicken. The hardened mattress is crushed by a crushing device to create a ground surface similar to a first feeding environment, and the crushed mattress is irradiated with a microwave field of a microwave device, thereby reducing or killing the number of various pathogenic bacteria such as chicken coccidiosis protozoa, viruses, bacteria, and fungi in the mattress. The broiler chicken can be healthily and safely raised by reducing the pathogenicity and the fatality rate, so that huge economic benefits are brought to poultry farms.
Owner:HOXBIO CO LTD

Application of resveratrol in preparation of medicine or feed additive for preventing and treating fish streptococcus iniae disease

The invention provides application of resveratrol in preparation of drugs or feed additives for preventing and treating fish streptococcus iniae diseases. The resveratrol has the remarkable activity of inhibiting the main virulence factor phosphoglucomutase (PGM) of streptococcus iniae, and the inhibition rate of the resveratrol to the activity of the PGM at the low concentration of 10 mu g / mL reaches 27.3%. A low-concentration natural compound is used as a virulence factor inhibitor to research and develop a medicine, is more economical, green and efficient, and is expected to be researched and developed into a natural green medicine for replacing antibiotics in aquaculture.
Owner:HAINAN UNIV +1

BcSPS1 gene and its application in reducing pathogenicity of botrytis cinerea

ActiveCN116479025Breduce pathogenicity
The BcSPS1 gene and application thereof in reducing pathogenicity of Botrytis cinerea belong to the field of microbial genetic engineering technology, and the BcSPS1 gene provided by the application has a DNA sequence as shown in SEQ ID No:1 and is composed of 1947 nucleotides; the protein encoded by the BcSPS1 gene has an amino acid sequence as shown in SEQ ID No:2 and is composed of 612 amino acids; the BcSPS1 gene can be applied in the field of plant Botrytis cinerea genetic engineering; and the BcSPS1 gene for controlling pathogenicity of Botrytis cinerea can be knocked out to make the pathogenicity of Botrytis cinerea defective and can be applied in reducing pathogenicity of Botrytis cinerea.
Owner:JILIN UNIVERSITY

Application of piperine in preparation of drugs and feed additives for preventing and treating vibriosis of aquatic animals

The invention provides application of piperine in preparation of drugs and feed additives for preventing and treating vibriosis of aquatic animals, and belongs to the technical field of prevention and control of bacterial diseases of the aquatic animals. According to the invention, piperine is applied to prevention and treatment of vibriosis of aquatic animals for the first time, especially vibriosis harveyi of pearl gentian groupers, the survival rate of pearl gentian groupers infected with vibriosis harveyi can be increased within an effective dose, and the relative protection rate reaches 49.99%.
Owner:HAINAN UNIV +1

FolRtt109 gene targeting agent and application thereof in inhibiting phytopathogen

The invention discloses a FolRtt109 gene targeting agent and an application of the FolRtt109 gene targeting agent in inhibition of phytopathogen. In the fusarium oxysporum, the pathogenicity of the fusarium oxysporum can be obviously inhibited by knocking out the gene FolRtt109, and the gene has a crucial relationship with the pathogenicity of the fusarium oxysporum. The gene is knocked out by using a homologous recombination method to obtain a gene knockout mutant, and the pathogenicity of the mutant to tomatoes is remarkably reduced. Experiments prove that by applying the FolRtt109 gene targeted medicament CID-4785700, infection of various phytopathogens such as fusarium oxysporum, botryis cinerea, fusarium graminearum and magnaporthe oryzae can be remarkably inhibited, the purpose of preventing and treating the various phytopathogens can be achieved, and the FolRtt109 gene targeted medicament CID-4785700 is simple in use method, free of influence on plant growth, safe, reliable and suitable for popularization and application. Wide application prospects are realized.
Owner:QINGDAO AGRI UNIV

Application of AST2 gene of banana wilt pathogen in regulating the pathogenicity of banana wilt pathogen

ActiveCN118562891Breduce pathogenicityBiocideTransferases
The present invention discloses the application of the AST2 gene of banana wilt pathogen in regulating the pathogenicity of banana wilt pathogen. The present invention utilizes the principle of homologous recombination to knock out the gene FocAST2; and utilizes the method of PEG-mediated protoplast transformation to obtain the knockout body. The results show that the knockout of the FocAST2 gene causes mycelium to curl and other growth deformities, significantly affects the spore production of the strain, reduces the content of α-ketoglutaric acid (α-KG), and increases the H 2 O 2 The content increased and the pathogenicity decreased, indicating that knocking out the FocAST2 gene affected the growth of banana wilt pathogen and reduced its pathogenicity. The present invention helps to further clarify the pathogenic molecular mechanism of banana wilt pathogen and provides a target gene for the development of effective fungicides.
Owner:POMOLOGY RES INST GUANGDONG ACADEMY OF AGRI SCI

Porcine rotavirus G5 type and application thereof

PendingCN119570745APromote rapid proliferationreduce pathogenicityViral antigen ingredientsVirus peptidesElisa kitAntiendomysial antibodies
The invention provides a porcine rotavirus G5 type and application thereof. According to the present invention, the porcine rotavirus G5 type SC05 strain is separated from the porcine intestinal tract tissue, and is subjected to passage purification to obtain the porcine rotavirus G5 type SC05 strain, and the microbial preservation number of the porcine rotavirus G5 type SC05 strain is CGMCC No.46179; the isolated strain can stably proliferate on passage cells to generate typical cytopathy. The G5 type isolated strain of the porcine rotavirus disclosed by the invention has excellent immunogenicity; the vaccine prepared from the isolated strain can induce piglets to generate high-level neutralizing antibodies; meanwhile, the ELISA kit prepared from the isolated strain can be used for well detecting the porcine rotavirus G5 type antibody in serum.
Owner:CHINA ANIMAL HUSBANDRY IND

A live attenuated strain of Staphylococcus aureus SdBd-6 and its application

This invention belongs to the field of biological control of plant diseases, specifically relating to a virulent strain of *Botrytis cinerea* SdBd-6 and its applications. The virulent strain of *Botrytis cinerea* SdBd-6 is classified and named... Botryosphaeria dothidea The attenuated strain SdBd-6 of Staphylococcus aureus was deposited at the Guangdong Provincial Center for Microbial Culture Collection on January 14, 2026, with accession number GDMCC: 67656. Walsa money The growth of the fungus has a certain inhibitory function. At the same time, after 10 generations of continuous inoculation, the virus contained in the attenuated strain SdBd-6 of *Botrytis cinerea* was not lost, and its growth characteristics and pathogenicity remained attenuated strain characteristics. This provides materials and lays the foundation for the green control of plant fungal diseases caused by the pathogenic fungus *Botrytis cinerea*.
Owner:SHANDONG AGRICULTURAL UNIVERSITY

Construction and application of gene VII type Newcastle disease attenuated marker vaccine strain rMG7-F-N471A

The invention discloses a gene VII type Newcastle disease attenuated marker vaccine strain rMG7-F-N471A, the preservation number of which is CGMCC (China General Microbiological Culture Collection Center) No.46293. The whole-genome nucleotide sequence of the vaccine strain is as shown in SEQ ID No: 1; wherein the 471st amino acid asparagine (N) of the F protein is replaced with alanine (A). A Newcastle disease virus reverse genetic manipulation platform is utilized, different sites are mutated on the basis of a Newcastle disease virus MG7 strain, a gene VII type Newcastle disease virus marker vaccine attenuated strain rMG7-F-N471A which is low in pathogenicity, good in growth characteristic, high in virus titer, stable in passage and excellent in immunogenicity is rescued, and the marker vaccine strain is good in immunogenicity, high in immunogenicity, high in immunogenicity, high in specificity, high in specificity, high in specificity and high in specificity. The vaccine can induce a high-level protective antibody, completely protects immunized chickens, can be used for preventing and controlling the current epidemic gene VII type Newcastle disease virus, and lays a foundation for identifying vaccine immunity and wild virus infection.
Owner:LANZHOU VETERINARY RESEARCH INSTITUTE CHINESE ACADEMY OF AGRICULTURAL SCIENCES(LANZHOU BRANCH CENTER OF CHINA ANIMAL HEALTH & EPIDEMIOLOGY CENTER)

Construction and application of gene VII type Newcastle disease attenuated marker vaccine strain rMG7-L-V1291I

The invention discloses a gene VII type Newcastle disease attenuated marker vaccine strain rMG7-L-V1291I, the preservation number of the gene VII type Newcastle disease attenuated marker vaccine strain rMG7-L-V1291I is CGMCC (China General Microbiological Culture Collection Center) No.46291, and the whole-genome nucleotide sequence of the vaccine strain is as shown in SEQ ID No: 1; wherein the 1291th amino acid valine (V) of the L protein is replaced by isoleucine (I). A Newcastle disease virus reverse genetic manipulation platform is utilized, different sites are mutated on the basis of a Newcastle disease virus MG7 strain, a gene VII type Newcastle disease virus marker vaccine attenuated strain rMG7-L-V1291I which is low in pathogenicity, good in growth characteristic, high in virus titer, stable in passage and excellent in immunogenicity is rescued, and the marker vaccine strain is good in immunogenicity, high in immunogenicity, high in specificity, high in immunogenicity and capable of being used as a marker vaccine for the Newcastle disease virus. The vaccine can induce a high-level protective antibody, completely protects immunized chickens, can be used for preventing and controlling the current epidemic gene VII type Newcastle disease virus, and lays a foundation for identifying vaccine immunity and wild virus infection.
Owner:LANZHOU VETERINARY RESEARCH INSTITUTE CHINESE ACADEMY OF AGRICULTURAL SCIENCES(LANZHOU BRANCH CENTER OF CHINA ANIMAL HEALTH & EPIDEMIOLOGY CENTER)

Sclerotinia sclerotiorum gene SsCRZ1 and application thereof in regulation and control of infection pad formation and pathopoiesis

PendingCN122038420Aweaken the ability to formreduce pathogenicityFungiMicroorganism based processesDiseaseMicrobial genetics
The invention discloses a sclerotinia sclerotiorum gene SsCRZ1 and application thereof in regulation and control of infection pad formation and pathopoiesis, and belongs to the technical field of microbial genetic engineering. The DNA sequence of the gene SsCRZ1 is as shown in SEQ ID NO: 1, and the amino acid sequence of the protein coded by the gene SsCRZ1 is as shown in SEQ ID NO: 2. Gene knockout and refilling experiments prove that the infection pad forming ability of sclerotinia sclerotiorum and the pathogenicity of sclerotinia sclerotiorum to host plants can be remarkably weakened by deletion of the SsCRZ1 gene, and the functions can be recovered by refilling the gene. Therefore, the SsCRZ1 gene is a gene necessary for formation and pathopoiesis of a sclerotinia sclerotiorum infection pad. According to the invention, the function of the SsCRZ1 gene in sclerotinia sclerotiorum is defined for the first time, and a theoretical basis is provided for the gene as a new target for prevention and control of sclerotiniose.
Owner:JILIN UNIVERSITY